Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Beta Cell Preservation”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Not applicableUnknownNCT03037190
What this trial is testing

Preservation of Residual Beta Cell Mass and Prevention of Celiac Disease in Children With Recent Onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1RemissionCeliac Disease in Children
Lund University 160
Not applicableStudy completedNCT06177691
What this trial is testing

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

Who this might be right for
Type1 Diabetes
Jaeb Center for Health Research 77
Large-scale testing (Phase 3)Study completedNCT00279045
What this trial is testing

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 4,426
Not applicableLooking for participantsNCT02969798
What this trial is testing

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

Who this might be right for
Diabetes Mellitus, Type 2Impaired Glucose Tolerance (IGT)Impaired Fasting Glucose (IFG)
The University of Texas Health Science Center at San Antonio 700
Testing effectiveness (Phase 2)Active Not RecruitingNCT05067621
What this trial is testing

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Type 2 Diabetes MellitusImpaired Glucose ToleranceNon-Alcoholic Fatty Liver Disease+1 more
Yale University 60
Testing effectiveness (Phase 2)Ended earlyNCT04524949
What this trial is testing

IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)

Who this might be right for
Diabetes Mellitus, Type 1
Imcyse SA 110
Large-scale testing (Phase 3)Study completedNCT04233034
What this trial is testing

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes

Who this might be right for
Type1 Diabetes
Jaeb Center for Health Research 113
Testing effectiveness (Phase 2)Ended earlyNCT04899271
What this trial is testing

Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

Who this might be right for
New-onset Type 1 Diabetes
Dompé Farmaceutici S.p.A 25
Testing effectiveness (Phase 2)Study completedNCT00420511
What this trial is testing

Beta-Cell Function and Sitagliptin Trial (BEST)

Who this might be right for
Type 2 Diabetes Mellitus
Samuel Lunenfeld Research Institute, Mount Sinai Hospital 21
Post-approval studies (Phase 4)Study completedNCT02853630
What this trial is testing

A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus

Who this might be right for
TYpe 2 Diabetes Mellitus
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals 203
Not applicableStudy completedNCT00232583
What this trial is testing

Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
University of Texas Southwestern Medical Center 58
Testing effectiveness (Phase 2)Study completedNCT02443155
What this trial is testing

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 308
Not applicableStudy completedNCT00574405
What this trial is testing

Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy

Who this might be right for
Diabetes Mellitus
Arkansas Children's Hospital Research Institute 24
Large-scale testing (Phase 3)Study completedNCT03215069
What this trial is testing

Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes

Who this might be right for
Gestational Diabetes
Mount Sinai Hospital, Canada 91
Not applicableUnknownNCT02871089
What this trial is testing

Closed Loop From Onset in Type 1 Diabetes

Who this might be right for
Diabetes MellitusType 1 Diabetes
University of Cambridge 96
Testing effectiveness (Phase 2)UnknownNCT05622123
What this trial is testing

BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation

Who this might be right for
Type 1 Diabetes
Radboud University Medical Center 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07430332
What this trial is testing

GLP-1 RA for Stage 1 Type 1 Diabetes

Who this might be right for
Stage 1 Diabetes Mellitus, Type 1
Children's Hospital Medical Center, Cincinnati 15
Post-approval studies (Phase 4)Study completedNCT01099618
What this trial is testing

Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment

Who this might be right for
Ketosis Prone DiabetesDiabetes KetoacidosisHyperglycemia
Dawn Smiley MD 48
Not applicableStudy completedNCT07307872
What this trial is testing

A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Neurodegenerative DiseaseDementia+1 more
Amoneta Diagnostics SAS 150
Testing effectiveness (Phase 2)Ended earlyNCT01222078
What this trial is testing

Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 1
Next Page